Filing of Form 20-F with SEC

FILING OF ANNUAL REPORT ON FORM 20-F WITH THE US SECURITIES AND EXCHANGE
COMMISSION

AstraZeneca PLC (the Company) announced today that it filed its Annual Report on
Form 20-F with the US Securities and Exchange Commission (SEC). The document is
available for viewing on the SEC website at www.sec.gov and also on the
Company's website at www.astrazeneca.com. The Company will send any holder of
the Company's securities, upon request, a hard copy of the Company's complete
audited financial statements free of charge. Requests may be made by writing to
the Company Secretary, AstraZeneca PLC, 2 Kingdom Street, London W2 6BD.

A C N Kemp

Company Secretary

8 March 2016